1-3 of 3
Nobuaki Nakano
Close
Sort by
Journal Articles

Improved survival of patients with aggressive ATL by increased use of allo-HCT: a prospective observational study

Clinical Trials & Observations
Ayumu Ito, Nobuaki Nakano, Takashi Tanaka, Shigeo Fuji, Junya Makiyama, Yoshitaka Inoue, Ilseung Choi, Hirohisa Nakamae, Koji Nagafuji, Ken Takase, Shinichiro Machida, Tsutomu Takahashi, Yasushi Sawayama, Tomohiko Kamimura, Koji Kato, Toshiro Kawakita, Masao Ogata, Rika Sakai, Souichi Shiratori, Kaoru Uchimaru, Yoshihiro Inamoto, Atae Utsunomiya, Takahiro Fukuda
Journal: Blood Advances
Blood Adv (2021) 5 (20): 4156–4166.
https://doi.org/10.1182/bloodadvances.2021004932
Published: 2021
Includes: Supplemental data
Journal Articles

Chromosomal defects and survival in patients with adult T-cell leukemia/lymphoma after allogeneic HSCT

Nobuaki Nakano, Atae Utsunomiya, Keitaro Matsuo, Noriaki Yoshida, Masao Seto, Kouichi Ohshima, Hiroshi Fujiwara, Shigeo Fuji, Yoshifusa Takatsuka, Ayumu Ito, Toshihiro Miyamoto, Youko Suehiro, Hirohisa Nakamae, Yasushi Sawayama, Mitsuhiro Yuasa, Yasuhiko Miyazaki, Shuichi Ota, Kazunori Imada, Takahiro Fukuda, Tatsuo Ichinohe, Yoshiko Atsuta, Koji Kato
Journal: Blood Advances
Blood Adv (2021) 5 (2): 475–486.
https://doi.org/10.1182/bloodadvances.2020003639
Published: 2021
Includes: Supplemental data
Journal Articles

Mogamulizumab for adult T-cell leukemia-lymphoma: a multicenter prospective observational study

Clinical Trials & Observations
Kentaro Yonekura, Shigeru Kusumoto, Ilseung Choi, Nobuaki Nakano, Asahi Ito, Youko Suehiro, Yoshitaka Imaizumi, Makoto Yoshimitsu, Kisato Nosaka, Eiichi Ohtsuka, Michihiro Hidaka, Tatsuro Jo, Hidenori Sasaki, Yukiyoshi Moriuchi, Masao Ogata, Hiro Tatetsu, Kenji Ishitsuka, Yasushi Miyazaki, Ryuzo Ueda, Atae Utsunomiya, Takashi Ishida
Journal: Blood Advances
Blood Adv (2020) 4 (20): 5133–5145.
https://doi.org/10.1182/bloodadvances.2020003053
Published: 2020
Includes: Supplemental data